PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cancer Biology, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL 32224, USA.\', \'Department of Microbiology and Plant Pathology, University of California, 900 University, Riverside, CA 92521, USA.\', \'Division of Engineering in Medicine, Department of Medicine, Brigham and Women\'s Hospital, Harvard Medical School, 65 Landsdowne St, Cambridge, MA 02139, USA.\', \'Department of Neurology, Mayo Clinic, 4500 San Pablo South, Jacksonville, FL 32224, USA.\', \'Department of Molecular, Cell and Systems Biology, University of California, 900 University, Riverside, CA 92521, USA.\', \'Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.\', \'Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.\', \'Department of Quantitative Health Science, Division of Computational Biology, Mayo Clinic, Jacksonville, FL 32224, USA.\', \'Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA.\', \'Department of Biochemistry & Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 78710.3390/biom11060787
?:hasPublicationType
?:journal
  • Biomolecules
is ?:pmid of
?:pmid
?:pmid
  • 34071060
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.552
?:rankingScore_hIndex
  • 28
?:title
  • Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34071060>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34071060>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all